M Rickard, Research Governance and GCP Manager Elizabeth Clough, R&D Governance Operations Manager Rachel Fay, Research Governance and GCP Manager

Similar documents
M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

Marie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Standard Operating Procedure

Standard Operating Procedure (SOP) Research and Development Office

Safety Reporting in Clinical Research Policy Final Version 4.0

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

STANDARD OPERATING PROCEDURE

Standard Operating Procedure (SOP)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

STANDARD OPERATING PROCEDURE

Research Staff Training

Document Title: Document Number:

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Trial Management: Trial Master Files and Investigator Site Files

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

STANDARD OPERATING PROCEDURE SOP 205

Adverse Event Reporting

Corporate. Research Governance Policy. Document Control Summary

Document Title: Version Control of Study Documents. Document Number: 023

Keele Clinical Trials Unit

STANDARD OPERATING PROCEDURE SOP 325

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Document Title: File Notes. Document Number: 024

Keele Clinical Trials Unit

STANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

STANDARD OPERATING PROCEDURE

Standard Operating Procedure (SOP) Research and Development Office

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Standard Operating Procedure (SOP) Research and Development Office

Study Monitoring Plan Template

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

STANDARD OPERATING PROCEDURE

Document Title: Research Database Application (ReDA) Document Number: 043

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

POLICY ON RESEARCH RELATED ADVERSE EVENT REPORTING

Management of Medical Emergencies in the King s Clinical Research Facility

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title:

Document Title: Investigator Site File. Document Number: 019

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Risk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research

Clinical. Medication Errors and Medicine Defect Reporting SOP. Document Control Summary. Contents

Document Title: Training Records. Document Number: SOP 004

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Document Title: Informed Consent for Research Studies

Human Research Governance Review Policy

Document Title: Research Database Application (ReDA) Document Number: 043

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

Blood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

3 HEALTH, SAFETY AND ENVIRONMENTAL PROTECTION

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

New European Union Clinical Trial Regulations

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

GCP INSPECTORATE GCP INSPECTIONS METRICS REPORT

Reference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

ABMU R&D Operational Framework

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

RD SOP12 Research Passport Honorary Contracts / Letters of Access

First inspection of a Legal Representative in the EU by local authority

Site Closedown Checklist for UoL Sponsored CTIMP Studies

Human Samples in Research

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

SOP19a & 19b: Standard Operating Procedure for (a) Safety Monitoring (especially Pharmacovigilance) & (b) Urgent Safety Measures

PROCEDURE Client Incident Response, Reporting and Investigation

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

GCP Training for Research Staff. Document Number: 005

Standard Operating Procedure CPFT/SOP006 GCP Training Procedure for Clinical Trial Staff

Guidance notes for patient safety and pharmacovigilance in patient support programmes

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

POLICY & PROCEDURE FOR INCIDENT REPORTING

14 th May Pharmacy Voice. 4 Bloomsbury Square London WC1A 2RP T E

CONTINUING HEALTHCARE POLICY

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

STANDARD OPERATING PROCEDURE

Policy for the Reporting and Management of Incidents Including Serious Incidents. Version Number: 006

Continuing Healthcare Policy

Human Research Ethics Review Policy

Document Title: Study Data SOP (CRFs and Source Data)

Hepatitis B Immunisation procedure SOP

Risk Assessment and Monitoring

STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES

Transcription:

Standard Operating Procedures (SOP) for: Reporting Incidents Related to Research SOP Number: 027 Version Number: 4.0 Effective Date: 03 rd September 2015 Review Date: 02 nd September 2018 Author: Reviewer: Reviewer: Authorisation: Name / Position Signature M Rickard, Research Governance and GCP Manager Elizabeth Clough, R&D Governance Operations Manager Rachel Fay, Research Governance and GCP Manager Sally Burtles, Director of Research Services and Business Development Date 13 th August 2015 Purpose and Objective: This SOP provides instruction to researchers regarding the reporting process when incidents occur that are related to research projects. Scope: This SOP applies to all staff involved in research using human participants at Barts Health NHS Trust and Queen Mary University of London. Abbreviations: BH Barts Health NHS Trust CRC Clinical Research Centre JRMO Joint Research Management Office QMUL Queen Mary University of London SAE Serious Adverse Event SOP Standard Operating Procedure SUSAR Suspected Unexpected Serious Adverse Reaction Definitions (if needed) Incident: An event occurring on QMUL or Barts Health NHS Trust premises, or in the course of work undertaken by QMUL or Barts Health staff that could have directly or indirectly led to harm or loss to participants of research, staff, visitors, contractors, QMUL or Barts Health NHS Trust. Serious incident: An incident that that did result in harm or loss. Relevant SOP s JRMO SOP 26a Pharmacovigilance and Safety Reporting for Sponsored CTIMPs/ ATMPs, JRMO SOP 26b Pharmacovigilance and Safety Reporting for Sponsored non-ctimps. SOP 27 Reporting Incidents Related to Research v4.0 Page 1 of 5

SOP Text Responsibility 1. Research Team/ Principal Investigator Activity Ensure that incidents are identified and the appropriate processes are followed. The process below must be followed whenever an incident that needs to be reported occurs during a research project. Examples of incidents occurring within research that would require reporting are: drug errors, near misses, needle-stick injuries, verbal abuse from a research participant or family member towards a research team member, disclosure of data or personal information etc. If an incident directly affects the health or well-being of a research participant, follow the processes in SOPs 26a (Pharmacovigilance and Safety Reporting for Sponsored CTIMPs/ATMPs) and 26b (Pharmacovigilance and Safety Reporting for Sponsored non-ctimps) as well to ensure that the event is reported appropriately. Examples of incidents that must be reported following the processes in SOPs 26a and 26b include a drug error on a trial of a medicinal product that results in a Serious Adverse Event (SAE). There are additional reporting processes in these circumstances. If there is any doubt as to whether an incident should be reported, contact the JRMO for advice. Please Note: All Suspected Unexpected Serious Adverse Reactions (SUSARs) occurring to Trust patients should be reported on the Trust incident system in addition to the other reporting requirements for SUSARs (outlined in SOPs 26 a and b). 2. Research Team/ Principal Investigator Ensure incidents are appropriately recorded and reported. Record all incidents (whether or not they involve research participants) on the relevant incident form(s). For incidents occurring on Barts Health NHS Trust premises, complete the appropriate Trust electronic incident form which is located on the Trust intranet, and follow the guidance provided there. For incidents occurring on QMUL premises, complete the QMUL incident form which is located on the QMUL intranet, and follow the guidance provided there. Some premises (e.g. the Wingate Institute, the Clinical Research Centre, the William Harvey Heart Centre) share joint custodianship. In such instances report incidents in line with both the Trust and QMUL guidance. SOP 27 Reporting Incidents Related to Research v4.0 Page 2 of 5

Assessment of incidents must be conducted in line with institutional policies and procedures. Please note: For incidents involving participants, additional documentation of the incident is required; incidents that directly affect the health or well-being of research participant/s must be recorded in the participants medical notes, (where applicable) and also in the investigator site file. SOP 27 Reporting Incidents Related to Research v4.0 Page 3 of 5

Flow Chart Incident occurs Identify incident Did this incident directly affect the health or wellbeing of a research participant? No Yes Refer to SOP 26a and SOP 26b Record incident in medical notes (if appropriate) and project file Did this incident occur on BH or QMUL premises? BH Complete Trust electronic incident form and follow guidance on intranet QMUL Complete QMUL incident form and follow guidance on intranet Joint BH and QMUL Complete Trust electronic incident form and QMUL incident form and follow guidance on both intranets Contact the JRMO for advice on SOP if the incident did not occur on BH or QMUL premises. SOP 27 Reporting Incidents Related to Research v4.0 Page 4 of 5

Change Control This section outlines changes from version 3.0 to version 4.0 of this SOP. Section Description of change Abbreviations, Sections added. Definitions, Relevant SOPs 1 Heading added. Reference to SOPs 26a and 26b added. Phrasing amended for clarity. 2 Heading added. Clarified that incidents may not involve research participants. Added paragraph regarding premises which share joint custodianship. 3 Heading added. Changed project file to investigator site file Flow chart Added. List of appendices No appendices for this SOP. List of Associated Documents No associated documents for this SOP. SOP 27 Reporting Incidents Related to Research v4.0 Page 5 of 5